share_log

Cantor Fitzgerald Initiates Coverage On Connect Biopharma Hldgs with Overweight Rating, Announces Price Target of $5

Cantor Fitzgerald Initiates Coverage On Connect Biopharma Hldgs with Overweight Rating, Announces Price Target of $5

坎託·菲茨傑拉德以增持評級啓動對Connect Biopharma Hldgs的報道,宣佈目標股價爲5美元
Benzinga Real-time News ·  2022/06/02 06:26

Cantor Fitzgerald analyst Louise Chen initiates coverage on Connect Biopharma Hldgs (NASDAQ:CNTB) with a Overweight rating and announces Price Target of $5.

Cantor Fitzgerald分析師Louise Chen在康乃德生物(納斯達克代碼:CNTB)上以增持評級發起報道,並宣佈目標價為5美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論